(3S,6E,22E)-9,10-Secoergosta-5(10),6,8,22-tetraen-3-ol
3-[(E)-2-[1-[(E)-5,6-二甲基庚-3-烯-2-基]-7alpha-甲基-1,2,3,3A,6,7-六氢茚-4-基]乙烯基]-4-甲基环己-3-烯-1-醇
基本信息

CAS号
115-61-7
分子式
C28H44O
分子量
396.659 g/mol
Quick Actions
基本物理性质
沸点
460.3°C (rough estimate)
闪点
218.1°C
折射率
1.5100 (estimate)
比旋光度
D18 -70° (24.6 mg in 2 ml petr ether); 18546 -86.3° (petr ether)
分类与用途
化学分类
医药产品
原料药及中间体
中间体
安全信息
同义词与参考文献
英文
- 3-CYCLOHEXEN-1-OL, 3-((1E)-2-((1R,3AR,7AR)-2,3,3A,6,7,7A-HEXAHYDRO-7A-METHYL-1-((1R,2E,4R)-1,4,5-TRIMETHYL-2-HEXEN-1-YL)-1H-INDEN-4-YL)ETHENYL)-4-METHYL-, (1S)-
- 9,10-Secoergosta-5(10),6,8,22-tetraen-3-ol, (3.beta.,6E,22E)-
- Tachysterol (>90%)
- (6E,22E)-(3S)-9,10-seco-5(10),6,8,22-ergostatetraen-3-ol
- 9SOR58S8QJ
- SCHEMBL601136
- ERGOCALCIFEROL IMPURITY E [EP IMPURITY]
- Tachysterol
- Tachysterin2
- UNII-9SOR58S8QJ
- TACHYSTEROL 2
- (6E,22E)-(3R)-9,10-Secoergosta-5(10),6,8,22-tetraen-3-ol
- LMST03010016
- EINECS 204-096-7
- 115-61-7
- tachysterol2
- TACHYSTEROL [MI]
- Q27273099
- DTXSID401019014
- XQFJZHAVTPYDIQ-LETJEVNCSA-N
- 3-Cyclohexen-1-ol,3-[(1E)-2-[(1R,3aR,7aR)-2,3,3a,6,7,7a-hexahydro-7a-methyl-1-[(1R,2E,4R)-1,4,5-trimethyl-2-hexen-1-yl]-1H-inden-4-yl]ethenyl]-4-methyl-,(1S)-
- (6E,22E)-(3R)-9,10-secoergosta-5(10),6,8,22-tetraen-3-ol
- (3S,6E,22E)-9,10-Secoergosta-5(10),6,8,22-tetraen-3-ol
- 3-Cyclohexen-1-ol,3-[(1E)-2-[(1R,3aR,7aR)-2,3,3a,6,7,7a-hexahydro-7a-methyl-1-[(1R,2E,4R)-1,4,5-trimethyl-2-hexen-1-yl]-1H-in
- Acetyldinaline
- Goe 5549
- N-acetyldinaline
- Tacedinalina
- tacedinaline
- Tachysterol2
- taxisterol2
- Einecs 204-096-7
- (6E,22E)-9,10-Secoergosta-5(10),6,8,22-tetrene-3β-ol
- (6E,22E)-9,10-Secoergosta-5(10),6,8,22-tetraen-3β-ol
- (S)-3-((E)-2-((1R,3aR,7aR)-1-((2R,5R,E)-5,6-dimethylhept-3-en-2-yl)-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl)vinyl)-4-methylcyclohex-3-en-1-ol
中文
- 速甾醇
- 2-(2-(苄氧基羰基氨基)(1,3-d6-丙烷)-2-基)-5-羰基-6-氧代-1,6-二氢嘧啶-4-甲酸甲酯
- 3-[(E)-2-[1-[(E)-5,6-二甲基庚-3-烯-2-基]-7alpha-甲基-1,2,3,3A,6,7-六氢茚-4-基]乙烯基]-4-甲基环己-3-烯-1-醇
CAS号
115-61-7
供应商信息
供应商名称 | 会员等级 | 认证状态 | 主要类别 | 最小订购量 | 操作 |
---|---|---|---|---|---|